Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Christy Shaffer
AddedMar 31, 2024
UpdatedJun 28, 2026
Christy Shaffer

Christy Shaffer

Board Member, Clearside Biomedical

CrunchbaseLinkedIn

Christy Shaffer's Career

Clearside Biomedical
Clearside Biomedical

Alpharetta, GA, US

Board Member· Board
Aer Therapeutics
Aer Therapeutics

Raleigh, NC, US

Board Member· Board
Artizan Biosciences
Artizan Biosciences

Durham, NC, US

Board Member· Board
Spyryx Biosciences
Spyryx Biosciences

Durham, NC, US

Board Member· Board
Trefoil Therapeutics
Trefoil Therapeutics

San Diego, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Christy Shaffer's Career

Clearside Biomedical
Clearside Biomedical
Public$188.9M362011Alpharetta, GA, US
Board Member· Board

Leadership at Clearside Biomedical

Mark PrausnitzMark PrausnitzCo-Founder
Bill HumphriesBill HumphriesBoard Member
Henry F EdelhauserHenry F EdelhauserCo-Founder
Ben YerxaBen YerxaBoard Member
Jeffrey L. EdwardsJeffrey L. EdwardsBoard Member
George LasezkayGeorge LasezkayCEO
Aer Therapeutics
Aer Therapeutics
Series A$36M122014Raleigh, NC, US
Board Member· Board

Leadership at Aer Therapeutics

Thomas MathersThomas MathersBoard Member
Rishi GuptaRishi GuptaBoard Member
John FahyJohn FahyFounder

Similar to Aer Therapeutics

Aerami TherapeuticsAerami TherapeuticsDurham, NC, USInhaled Therapiesest. 2010Aerami TherapeuticsDurham, NC, US · est. 2010

Aerami Therapeutics: Innovating inhaled therapies for severe respiratory and chronic diseases.

Series B · $133.5M18
Aero TherapeuticsAero TherapeuticsSan Diego, CA, USMedical Devicesest. 2019Aero TherapeuticsSan Diego, CA, US · est. 2019

Aero Therapeutics: Developing respiratory aid devices for low-resource settings.

Seed · $180k6
Aerwave MedicalAerwave MedicalNaples, FL, USMedical Devicesest. 2020Aerwave MedicalNaples, FL, US · est. 2020

Aerwave Medical: Pioneering non-drug COPD and asthma treatments since 2020, based in New York.

Seed · $8M7
PulmatrixPulmatrixLexington, MA, USTherapeuticsest. 2003PulmatrixLexington, MA, US · est. 2003

Pulmatrix, Inc.: A US-based biotech firm specializing in therapies for chronic respiratory diseases.

Public · $148.4M24
Artizan Biosciences
Artizan Biosciences
Series A$33.9M262016Durham, NC, US
Board Member· Board

Leadership at Artizan Biosciences

Seth RudnickSeth RudnickBoard Member
Moncef SlaouiMoncef SlaouiBoard Member
Richard FlavellRichard FlavellCo-Founder
Marcel de ZoeteMarcel de ZoeteCo-Founder
Noah PalmNoah PalmCo-Founder
Bridget MartellBridget MartellCEO
Spyryx Biosciences
Spyryx Biosciences
Series A$18.2M302013Durham, NC, US
Board Member· Board

Leadership at Spyryx Biosciences

Brian DanielsBrian DanielsBoard Member
Robert TarranRobert TarranFounder
Roger JeffsRoger JeffsBoard Member
Tim ShannonTim ShannonBoard Member
John C TaylorJohn C TaylorCEO

Similar to Spyryx Biosciences

SphynKx TherapeuticsSphynKx TherapeuticsCharlottesville, VA, USBiotechnology, Therapiesest. 2010SphynKx TherapeuticsCharlottesville, VA, US · est. 2010

SphynKx Therapeutics: Innovating biotech solutions for cancer and fibrosis treatment.

Seed · $50k30
SynspiraSynspiraFramingham, MA, USBiotechest. 2017SynspiraFramingham, MA, US · est. 2017

Synspira Therapeutics: A clinical-stage biotech firm innovating treatments for cystic fibrosis and rare diseases.

Series B · $25.2M8
PulmatrixPulmatrixLexington, MA, USTherapeuticsest. 2003PulmatrixLexington, MA, US · est. 2003

Pulmatrix, Inc.: A US-based biotech firm specializing in therapies for chronic respiratory diseases.

Public · $148.4M24
Spirrow TherapeuticsSpirrow TherapeuticsBoston, MA, USLung Restorationest. 2018Spirrow TherapeuticsBoston, MA, US · est. 2018

Spirrow Therapeutics: Innovating lung restoration for ARDS-affected babies using proprietary methods.

Angel · $256k6
Trefoil Therapeutics
Trefoil Therapeutics
Series A$85.8M182014San Diego, CA, US
Board Member· Board

Leadership at Trefoil Therapeutics

Ken ThomasKen ThomasCo-Founder
Ralph BradshawRalph BradshawCo-Founder
Ben McGrawBen McGrawBoard Member
Stella RobertsonStella RobertsonBoard Member
Derek YoonDerek YoonBoard Member
Michael BlaberMichael BlaberCo-Founder

Christy Shaffer's Co-Investors

J Thomas McMurrayJ Thomas McMurrayCo-invested · EvoApp Series ATom DardenTom DardenCo-invested · EvoApp Series ATimothy BuckleyTimothy BuckleyCo-invested · EvoApp Series AElias ZerhouniElias ZerhouniCo-invested · EvoApp Series AKimberly JenkinsKimberly JenkinsCo-invested · EvoApp Series ASteve NelsonSteve NelsonCo-invested · EvoApp Series AJim ZiperskiJim ZiperskiCo-invested · EvoApp Series AHenry KaestnerHenry KaestnerCo-invested · EvoApp Series A

Christy Shaffer's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Christy Shaffer

Lee M GravesLee M GravesCo-Founder · KinoDynGary JohnsonGary JohnsonCo-Founder · KinoDynJian JinJian JinCo-Founder · KinoDynEric M StoneEric M StoneBoard Member · AnswersNowSanjay ChandraSanjay ChandraBoard Member · eLearning BrothersErin EnrightErin EnrightBoard Member · Dynatronics